🎗️ Ovarian Cancer Fagotti Laparoscopic Score
UseLaparoscopic resectability assessment to guide primary debulking vs neoadjuvant chemotherapy in advanced ovar…
Loading calculator…
SourceFagotti A, et al. A laparoscopy-based score to predict surgical outcome in patients with advanced o…
Runs locally in your browser (no PHI uploaded). For licensed clinicians — not a substitute for clinical judgement.
Stored on this device for revisit reminders
This-shift next steps
After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.
Scene next step
📋gyn oncoOpen scene pack →Related scores
Matching pathway
🧭cervical_ca_mriOpen pathway →Score + version; reference only — not a substitute for care · no HIS write
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
Methodology · worked example, guidelines & full notes
Clinical takeaway
Optimal cytoreduction here is defined as residual disease < 1 cm.
When to use
Laparoscopic resectability assessment to guide primary debulking vs neoadjuvant chemotherapy in advanced ovarian cancer.
How it works
Predictive index value (PIV) = sum of 7 findings each 0 or 2 (peritoneal/diaphragmatic carcinomatosis, mesenteric retraction, omental cake, bowel/stomach infiltration, liver surface metastasis), max 14. PIV ≥ 8 → optimal cytoreduction unlikely.
Key points
- Optimal cytoreduction here is defined as residual disease < 1 cm.
- A PIV ≥ 8 has a very high specificity/PPV for failing optimal cytoreduction and favours neoadjuvant chemotherapy + interval debulking.
- Diagnostic laparoscopy reduces the rate of futile (open-and-close) laparotomy.
- Complementary to the Suidan score (CT/clinical) and overall fitness and imaging assessment.
References
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Peritoneal carcinomatosis (extensive/miliary, unresectable) | No (0) |
|---|---|
| Diaphragmatic carcinomatosis (extensive infiltration/confluent nodules) | No (0) |
| Mesenteric retraction (root infiltration/retraction) | No (0) |
| Omental cake (spread to the greater curvature of the stomach) | No (0) |
| Bowel infiltration (resection required / serosal miliary) | No (0) |
| Stomach infiltration (gastric wall involvement) | No (0) |
| Liver surface metastasis (surface lesion > 2 cm) | No (0) |
→PIV0 pts
- Predictive index value (PIV)：0 pts (max 14) → < 8: optimal cytoreduction is relatively likely achievable
- Decision direction：Favour primary debulking surgery (PDS)
- Notes：Fagotti laparoscopic score: 7 findings each 0/2 (peritoneal/diaphragmatic carcinomatosis, mesenteric retraction, omental cake, bowel/stomach infiltration, liver surface metastasis); optimal cytoreduction defined as residual < 1 cm; diagnostic laparoscopy reduces the futile-laparotomy rate. Must be combined with performance status, imaging (Suidan/CT) and surgeon experience
| Peritoneal carcinomatosis (extensive/miliary, unresectable) | Yes (2) |
|---|---|
| Diaphragmatic carcinomatosis (extensive infiltration/confluent nodules) | Yes (2) |
| Mesenteric retraction (root infiltration/retraction) | Yes (2) |
| Omental cake (spread to the greater curvature of the stomach) | Yes (2) |
| Bowel infiltration (resection required / serosal miliary) | Yes (2) |
| Stomach infiltration (gastric wall involvement) | Yes (2) |
| Liver surface metastasis (surface lesion > 2 cm) | Yes (2) |
→PIV14 pts
- Predictive index value (PIV)：14 pts (max 14) → ≥ 8: low likelihood of optimal cytoreduction (residual < 1 cm) (specificity/PPV ≈ 100%)
- Decision direction：Favour neoadjuvant chemotherapy (NACT) + interval debulking surgery (IDS); avoid a futile laparotomy
- Notes：Fagotti laparoscopic score: 7 findings each 0/2 (peritoneal/diaphragmatic carcinomatosis, mesenteric retraction, omental cake, bowel/stomach infiltration, liver surface metastasis); optimal cytoreduction defined as residual < 1 cm; diagnostic laparoscopy reduces the futile-laparotomy rate. Must be combined with performance status, imaging (Suidan/CT) and surgeon experience
Verification & sources · governance
FAQ
Frequently asked questions
- What are the limits and cautions when using Ovarian Cancer Fagotti Laparoscopic Score?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- Does Ovarian Cancer Fagotti Laparoscopic Score upload patient data? Where is it calculated?
- Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
- How is Ovarian Cancer Fagotti Laparoscopic Score calculated in practice? Can you show a worked example?
- Inputs: Peritoneal carcinomatosis (extensive/miliary, unresectable) No (0), Diaphragmatic carcinomatosis (extensive infiltration/confluent nodules) No (0), Mesenteric retraction (root infiltration/retraction) No (0), Omental cake (spread to the greater curvature of the stomach) No (0), Bowel infiltration (resection required / serosal miliary) No (0), Stomach infiltration (gastric wall involvement) No (0), Liver surface metastasis (surface lesion > 2 cm) No (0) → Result: PIV 0 pts（Predictive index value (PIV): 0 pts (max 14) → < 8: optimal cytoreduction is relatively likely achievable, Decision direction: Favour primary debulking surgery (PDS), Notes: Fagotti laparoscopic score: 7 findings each 0/2 (peritoneal/diaphragmatic carcinomatosis, mesenteric retraction, omental cake, bowel/stomach infiltration, liver surface metastasis); optimal cytoreduction defined as residual < 1 cm; diagnostic laparoscopy reduces the futile-laparotomy rate. Must be combined with performance status, imaging (Suidan/CT) and surgeon experience） Inputs: Peritoneal carcinomatosis (extensive/miliary, unresectable) Yes (2), Diaphragmatic carcinomatosis (extensive infiltration/confluent nodules) Yes (2), Mesenteric retraction (root infiltration/retraction) Yes (2), Omental cake (spread to the greater curvature of the stomach) Yes (2), Bowel infiltration (resection required / serosal miliary) Yes (2), Stomach infiltration (gastric wall involvement) Yes (2), Liver surface metastasis (surface lesion > 2 cm) Yes (2) → Result: PIV 14 pts（Predictive index value (PIV): 14 pts (max 14) → ≥ 8: low likelihood of optimal cytoreduction (residual < 1 cm) (specificity/PPV ≈ 100%), Decision direction: Favour neoadjuvant chemotherapy (NACT) + interval debulking surgery (IDS); avoid a futile laparotomy, Notes: Fagotti laparoscopic score: 7 findings each 0/2 (peritoneal/diaphragmatic carcinomatosis, mesenteric retraction, omental cake, bowel/stomach infiltration, liver surface metastasis); optimal cytoreduction defined as residual < 1 cm; diagnostic laparoscopy reduces the futile-laparotomy rate. Must be combined with performance status, imaging (Suidan/CT) and surgeon experience）